Remote Patient Monitoring Market - Global Outlook & Forecast 2022-2027

Remote Patient Monitoring Market - Global Outlook & Forecast 2022-2027

In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Remote Patient Monitoring Market Report

The global remote patient monitoring market to grow at a CAGR of 12.5% during 2021-2027.

Remote patient monitoring is achieved by using digital technologies to monitor and capture medical health-related data from patients and electronically transmit the information to healthcare providers for assessment, and, when necessary, recommendations and instructions are provided. RPM reduces the number of readmissions in the medical requirement, hospitalizations, and duration of stay in the hospital, which leads to improved quality of life and contain costs.

In August 2020, Stasis Labs introduced a mobile-connected remote patient monitoring technology in hospitals and outpatient settings in the US. The company's Stasis system monitors important vital parameters in its functioning.

In July 2020, Philips and BioIntelliSense teamed together to improve remote patient monitoring systems for at-risk patients from the hospital to their homes. Philips has added the BioIntelliSense sensor to the device for remotely usage.

REMOTE PATIENT MONITORING MARKET SEGMENT

The Devices and Software segment accounted for the largest share in the global remote patient monitoring market. With the emergence of connected cardiac implants, cardiology was one of the first specialties to incorporate RPM. Cardiology practices are now particularly well-positioned to gain the short and long-term benefits associated with the progression of RPM services, technology, and regulation. The cardiac monitoring market is further propelled by innovative product characteristics, as well as the increased need and demand for virtual care solutions in the COVID-19 era. The cardiac monitor segment accounted for the maximum share in the remote patient monitoring market. For instance, according to CDC, 30.3 million US adults were identified with heart disorders in 2018. Thus, the high prevalence of cardiac disorder is expected to drive the segment.

Component:

  • Devices and Software
  • Cardiac Monitoring Devices
 Electrocardiographs (ECGs)

 Cardiac monitors

 Blood Pressure Monitor

 Others
  • Respiratory Monitoring Devices
 Apnea monitor

 Pulse Oximeters

 Others
  • Blood Glucose Monitors
 Continuous Blood Glucose Monitors (CGM)
  • Fetal & neonatal monitoring devices
  • Other RPM
  • Service
Application
  • Cardiology
  • Endocrinology
  • Pulmonology
  • Others
End-User
  • Hospitals & Specialty Clinics
  • Home Care Settings
  • Ambulatory Surgical Centers
  • Long-term & Acute Care Centers
  • Other
GEOGRAPHIC OVERVIEW

North America accounted for a significant 40% of the global market for remote patient monitoring market share in 2021. The presence of substantial competitors and their growth strategies are the main factors driving the North American market. The industry is driven by rising healthcare spending and increased awareness about the benefits of sickness prevention. An increase in heart ailments, sedentary lifestyles, and the deployment of e-health in some rural areas of North America is expected to drive the market growth.

Geography
  • North America
  • US
  • Canada
  • Europe
  • UK
  • Germany
  • Italy
  • France
  • Spain
  • APAC
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • MEA
  • Turkey
  • Saudi Arabia
  • South Africa
COMPETITIVE LANDSCAPE

With many top companies in the global market and several small players in regional markets, the global remote patient monitoring market is somewhat fragmented. The major competitors in the market are focusing their efforts on reducing the size of the remote patient monitoring market. These companies are also attempting to increase their market share by launching new goods and forming collaborations with other market participants. As a result, these factors are expected to propel the remote patient monitoring market growth.

Top Players
  • Medtronic
  • Philips Healthcare
  • ResMed
Other Prominent Players
  • Resideo
  • Honeywell
  • LST (LifeScience Technologies)
  • Coforge
  • Withings
  • MedM
  • iHealthUnifiedcare
  • Qardio
  • 100-Plus
  • A&D
  • Abbott
  • AltumView Systems
  • Biotronik
  • Boston Scientific
  • Bardy Diagnostics
  • Cardiomo
  • Cardiologs
  • Dragerwerk AG
  • Hoffmann-La Roche
  • GE Healthcare
  • GrandCare
  • Masimo Corporation
  • Medopad
  • Nihon Kohden
  • Omron Healthcare
  • OSPLabs
  • Smiths Medical
  • Spacelabs
  • Senseonics
  • TeleMedCare
  • VitalConnect
  • Vitls
  • Modicare
  • Hillrom
  • Vivify Health
  • ACL Digital
  • Dexcom
  • iRhythm Technologies
  • Vivalink
  • Biobeat
  • CareValidate
  • Biofourmis
  • CAREMINDr
  • Datos Health
THE REPORT INCLUDES:

1. The analysis of the global Remote Patient Monitoring market provides market size and growth rate for the forecast period 2022-2027.

2. It offers comprehensive insights into current industry trends, trend forecast, and growth drivers about the global Remote Patient Monitoring market.

3. The report provides the latest analysis of market share, growth drivers, challenges, and investment opportunities.

4. It offers a complete overview of market segments and the regional outlook of the Remote Patient Monitoring market.

5. The report offers a detailed overview of the vendor landscape, competitive analysis, and critical market strategies to gain competitive advantage.


1 RESEARCH METHODOLOGY
2 RESEARCH OBJECTIVES
3 RESEARCH PROCESS
4 SCOPE & COVERAGE
4.1 MARKET DEFINITION
4.1.1 INCLUSIONS
4.1.2 EXCLUSIONS
4.1.3 MARKET ESTIMATION CAVEATS
4.2 BASE YEAR
4.3 SCOPE OF THE STUDY
4.3.1 MARKET SEGMENTATION BY COMPONENT
4.3.2 MARKET SEGMENTATION BY APPLICATION
4.3.3 MARKET SEGMENTATION BY END-USER
4.3.4 MARKET SEGMENTATION BY GEOGRAPHY
5 REPORT ASSUMPTIONS & CAVEATS
5.1 KEY CAVEATS
5.2 CURRENCY CONVERSION
5.3 MARKET DERIVATION
6 MARKET AT A GLANCE
7 INTRODUCTION
7.1 OVERVIEW
7.1.1 COVID-19 IMPACT ON REMOTE PATIENT MONITORING MARKET
8 MARKET OPPORTUNITIES & TRENDS
8.1 INCREASING ROLE OF IOT IN REMOTE MONITORING & HEALTHCARE APPLICATIONS
8.2 PARADIGM SHIFT TOWARD HOME-BASED HEALTHCARE DEVICES
8.3 TELEMEDICINE USHERING NEW OPPORTUNITIES IN REMOTE MONITORING
9 MARKET GROWTH ENABLERS
9.1 AGING POPULATION VULNERABLE TO CHRONIC DISEASES
9.2 RISING WEARABLE MEDICAL TECHNOLOGY INNOVATIONS
9.3 GROWING USE OF RPM TO PROACTIVELY MONITOR & IMPROVE PATIENT ENGAGEMENT
9.4 INCREASED DEMAND FOR REMOTE MONITORING DUE TO COVID-19
10 MARKET GROWTH RESTRAINTS
10.1 LOW AWARENESS OF REMOTE MONITORING IN DEVELOPING COUNTRIES
10.2 LACK OF DATA ACCURACY
11 MARKET LANDSCAPE
11.1 MARKET OVERVIEW
11.2 MARKET SIZE & FORECAST
11.2.1 MARKET SHARE BY COMPONENT
11.2.2 MARKET SHARE BY DEVICES & SOFTWARE
11.2.3 MARKET SHARE BY APPLICATION
11.2.4 MARKET SHARE BY END-USER
11.2.5 MARKET BY GEOGRAPHY
11.3 FIVE FORCES ANALYSIS
11.3.1 THREAT OF NEW ENTRANTS
11.3.2 BARGAINING POWER OF SUPPLIERS
11.3.3 BARGAINING POWER OF BUYERS
11.3.4 THREAT OF SUBSTITUTES
11.3.5 COMPETITIVE RIVALRY
12 COMPONENT
12.1 MARKET SNAPSHOT & GROWTH ENGINE
13 DEVICES & SOFTWARE
13.1 MARKET SNAPSHOT & GROWTH ENGINE
13.2 MARKET OVERVIEW
13.3 CARDIAC MONITORING DEVICES
13.3.1 MARKET OVERVIEW
13.3.2 MARKET SIZE & FORECAST
13.3.3 CARDIAC MONITORING DEVICES: MARKET BY GEOGRAPHY
13.4 ELECTROCARDIOGRAPHS (ECGS)
13.4.1 MARKET OVERVIEW
13.4.2 ELECTROCARDIOGRAM (ECG): MARKET SIZE & FORECAST
13.5 CARDIAC MONITORS
13.5.1 MARKET OVERVIEW
13.5.2 CARDIAC MONITORS: MARKET SIZE & FORECAST
13.6 BLOOD PRESSURE MONITORS
13.6.1 MARKET OVERVIEW
13.6.2 MARKET SIZE & FORECAST
13.7 OTHER CARDIAC MONITORING DEVICES
13.7.1 MARKET OVERVIEW
13.7.2 MARKET SIZE & FORECAST
13.8 RESPIRATORY MONITORING DEVICES
13.8.1 MARKET OVERVIEW
13.8.2 MARKET SIZE & FORECAST
13.8.3 RESPIRATORY MONITORING DEVICES: MARKET BY GEOGRAPHY
13.9 APNEA MONITORS
13.9.1 MARKET OVERVIEW
13.9.2 MARKET SIZE & FORECAST
13.10 PULSE OXIMETERS
13.10.1 MARKET OVERVIEW
13.10.2 MARKET SIZE & FORECAST
13.11 OTHER RESPIRATORY MONITORING DEVICES
13.11.1 MARKET OVERVIEW
13.11.2 MARKET SIZE & FORECAST
13.12 BLOOD GLUCOSE MONITORS
13.12.1 MARKET OVERVIEW
13.12.2 MARKET SIZE & FORECAST
13.12.3 BLOOD GLUCOSE MONITORS: MARKET BY GEOGRAPHY
13.13 FETAL & NEONATAL MONITORING DEVICES
13.13.1 MARKET OVERVIEW
13.13.2 MARKET SIZE & FORECAST
13.13.3 FETAL & NEONATAL MONITORING DEVICES: MARKET BY GEOGRAPHY
13.14 OTHER RPM DEVICES
13.14.1 MARKET OVERVIEW
13.14.2 MARKET SIZE & FORECAST
13.14.3 OTHER RPM DEVICES: MARKET BY GEOGRAPHY
13.15 SERVICES
13.15.1 MARKET OVERVIEW
13.15.2 MARKET SIZE & FORECAST
13.15.3 REMOTE PATIENT MONITORING SERVICES: MARKET BY GEOGRAPHY
14 APPLICATION
14.1 MARKET SNAPSHOT & GROWTH ENGINE
14.2 MARKET OVERVIEW
14.3 CARDIOLOGY
14.3.1 MARKET OVERVIEW
14.3.2 MARKET SIZE & FORECAST
14.3.3 CARDIOLOGY REMOTE PATIENT MONITORING: MARKET BY GEOGRAPHY
14.4 PULMONOLOGY
14.4.1 MARKET OVERVIEW
14.4.2 MARKET SIZE & FORECAST
14.4.3 PULMONOLOGY REMOTE PATIENT MONITORING: MARKET BY GEOGRAPHY
14.5 ENDOCRINOLOGY
14.5.1 MARKET OVERVIEW
14.5.2 MARKET SIZE & FORECAST
14.5.3 REMOTE ENDOCRINOLOGY PATIENT MONITORING: MARKET BY GEOGRAPHY
14.6 OTHERS
14.6.1 MARKET OVERVIEW
14.6.2 MARKET SIZE & FORECAST
14.6.3 OTHER: MARKET BY GEOGRAPHY
15 END-USER
15.1 MARKET SNAPSHOT & GROWTH ENGINE
15.2 MARKET OVERVIEW
15.3 HOSPITALS & SPECIALTY CLINICS
15.3.1 MARKET OVERVIEW
15.3.2 MARKET SIZE & FORECAST
15.3.3 HOSPITALS & SPECIALTY CLINICS: MARKET BY GEOGRAPHY
15.4 HOMECARE SETTINGS
15.4.1 MARKET OVERVIEW
15.4.2 MARKET SIZE & FORECAST
15.4.3 HOMECARE SETTINGS: MARKET BY GEOGRAPHY
15.5 AMBULATORY SURGICAL CENTERS
15.5.1 MARKET OVERVIEW
15.5.2 MARKET SIZE & FORECAST
15.5.3 AMBULATORY SURGICAL CENTERS: MARKET BY GEOGRAPHY
15.6 LONG-TERM & ACUTE CARE CENTERS
15.6.1 MARKET OVERVIEW
15.6.2 MARKET SIZE & FORECAST
15.6.3 LONG-TERM & ACUTE CARE CENTERS: MARKET BY GEOGRAPHY
15.7 OTHERS
15.7.1 MARKET OVERVIEW
15.7.2 MARKET SIZE & FORECAST
15.7.3 OTHERS: MARKET BY GEOGRAPHY
16 GEOGRAPHY
16.1 MARKET SNAPSHOT & GROWTH ENGINE
16.2 GEOGRAPHIC OVERVIEW
17 NORTH AMERICA
17.1 MARKET OVERVIEW
17.2 MARKET SIZE & FORECAST
17.3 NORTH AMERICA: COMPONENT SEGMENTATION (REVENUE)
17.4 NORTH AMERICA: APPLICATION SEGMENTATION (REVENUE)
17.5 NORTH AMERICA: END-USER SEGMENTATION (REVENUE)
17.6 NORTH AMERICA: KEY COUNTRIES
17.6.1 US: MARKET SIZE & FORECAST
17.6.2 CANADA: MARKET SIZE & FORECAST
18 EUROPE
18.1 MARKET OVERVIEW
18.2 MARKET SIZE & FORECAST
18.3 EUROPE: COMPONENT SEGMENTATION (REVENUE)
18.4 EUROPE: APPLICATION SEGMENTATION (REVENUE)
18.5 EUROPE: END-USER SEGMENTATION (REVENUE)
18.7 EUROPE: KEY COUNTRIES
18.7.1 GERMANY: MARKET SIZE & FORECAST
18.7.2 UK: MARKET SIZE & FORECAST
18.7.3 FRANCE: MARKET SIZE & FORECAST
18.7.4 SPAIN: MARKET SIZE & FORECAST
18.7.5 ITALY: MARKET SIZE & FORECAST
19 APAC
19.1 MARKET OVERVIEW
19.2 MARKET SIZE & FORECAST
19.3 APAC: COMPONENT SEGMENTATION (REVENUE)
19.4 APAC: APPLICATION SEGMENTATION (REVENUE)
19.5 APAC: END-USER SEGMENTATION (REVENUE)
19.6 APAC: KEY COUNTRIES
19.6.1 CHINA: MARKET SIZE & FORECAST
19.6.2 JAPAN: MARKET SIZE & FORECAST
19.6.3 INDIA: MARKET SIZE & FORECAST
19.6.4 AUSTRALIA: MARKET SIZE & FORECAST
19.6.5 SOUTH KOREA: MARKET SIZE & FORECAST
20 LATIN AMERICA
20.1 MARKET OVERVIEW
20.2 MARKET SIZE & FORECAST
20.3 LATIN AMERICA: COMPONENT SEGMENTATION (REVENUE)
20.4 LATIN AMERICA: APPLICATION SEGMENTATION (REVENUE)
20.5 LATIN AMERICA: END-USER SEGMENTATION (REVENUE)
20.6 LATIN AMERICA: KEY COUNTRIES
20.6.1 MEXICO: MARKET SIZE & FORECAST
20.6.2 ARGENTINA: MARKET SIZE & FORECAST
20.6.3 BRAZIL: MARKET SIZE & FORECAST
21 MIDDLE EAST & AFRICA
21.1 MARKET OVERVIEW
21.2 MARKET SIZE & FORECAST
21.3 MIDDLE EAST & AFRICA: COMPONENT SEGMENTATION (REVENUE)
21.4 MIDDLE EAST & AFRICA: APPLICATION SEGMENTATION (REVENUE)
21.5 MIDDLE EAST & AFRICA: END-USER SEGMENTATION (REVENUE)
21.6 MIDDLE EAST & AFRICA: KEY COUNTRIES
21.6.1 TURKEY: MARKET SIZE & FORECAST
21.6.2 SAUDI ARABIA: MARKET SIZE & FORECAST
21.6.3 SOUTH AFRICA: MARKET SIZE & FORECAST
22 COMPETITIVE LANDSCAPE
22.1 MARKET SHARE ANALYSIS
22.1.1 MEDTRONIC
22.1.2 PHILIPS HEALTHCARE
22.1.3 RESMED
22.2 MARKET SHARE ANALYSIS OVERVIEW BY SERVICES
22.2.1 WITHINGS
22.2.2 MEDM
22.2.3 IHEALTHUNIFIEDCARE
22.2.4 QARDIO
23 KEY VENDORS
23.1 MEDTRONIC
23.1.1 BUSINESS OVERVIEW
23.1.2 PRODUCT OFFERING
23.2 PHILIPS HEALTHCARE
23.2.1 BUSINESS OVERVIEW
23.2.2 PRODUCT OFFERING
23.3 RESMED
23.3.1 BUSINESS OVERVIEW
23.3.2 PRODUCT OFFERING
24 OTHER PROMINENT VENDORS
24.1 RESIDEO TECHNOLOGIES
24.1.1 BUSINESS OVERVIEW
24.1.2 PRODUCT OFFERING
24.2 HONEYWELL INTERNATIONAL
24.2.1 BUSINESS OVERVIEW
24.3 LIFESCIENCE TECHNOLOGIES
24.3.1 BUSINESS OVERVIEW
24.3.2 PRODUCT OFFERING
24.4 COFORGE
24.4.1 BUSINESS OVERVIEW
24.4.2 PRODUCT OFFERING
24.5 WITHINGS
24.5.1 BUSINESS OVERVIEW
24.5.2 PRODUCT OFFERING
24.6 MEDM
24.6.1 BUSINESS OVERVIEW
24.6.2 PRODUCT OFFERING
24.7 IHEALTHUNIFIEDCARE
24.7.1 BUSINESS OVERVIEW
24.7.2 PRODUCT OFFERINGS
24.8 QARDIO
24.8.1 BUSINESS OVERVIEW
24.8.2 PRODUCT OFFERINGS
24.9 100-PLUS
24.9.1 BUSINESS OVERVIEW
24.9.2 PRODUCT OFFERINGS
24.10 A&D COMPANY
24.10.1 BUSINESS OVERVIEW
24.10.2 PRODUCT OFFERINGS
24.11 ABBOTT
24.11.1 BUSINESS OVERVIEW
24.11.2 PRODUCT OFFERINGS
24.12 ALTUMVIEW SYSTEMS
24.12.1 BUSINESS OVERVIEW
24.12.2 PRODUCT OFFERINGS
24.13 BIOTRONIK
24.13.1 BUSINESS OVERVIEW
24.13.2 PRODUCT OFFERING
24.14 BOSTON SCIENTIFIC
24.14.1 BUSINESS OVERVIEW
24.14.2 PRODUCT OFFERINGS
24.15 BARDY DIAGNOSTICS
24.15.1 BUSINESS OVERVIEW
24.15.2 PRODUCT OFFERINGS
24.16 CARDIOMO CARE
24.16.1 BUSINESS OVERVIEW
24.16.2 PRODUCT OFFERINGS
24.17 CARDIOLOGS
24.17.1 BUSINESS OVERVIEW
24.17.2 PRODUCT OFFERINGS
24.18 DRAGERWERK AG
24.18.1 BUSINESS OVERVIEW
24.18.2 PRODUCT OFFERINGS
24.19 F. HOFFMANN-LA ROCHE
24.19.1 BUSINESS OVERVIEW
24.19.2 PRODUCT OFFERINGS
24.20 GE HEALTHCARE
24.20.1 BUSINESS OVERVIEW
24.20.2 PRODUCT OFFERINGS
24.21 GRANDCARE SYSTEMS
24.21.1 BUSINESS OVERVIEW
24.21.2 PRODUCT OFFERINGS
24.22 MASIMO CORPORATION
24.22.1 BUSINESS OVERVIEW
24.22.2 PRODUCT OFFERINGS
24.23 MEDOPAD
24.23.1 BUSINESS OVERVIEW
24.23.2 PRODUCT OFFERINGS
24.24 NIHON KOHDEN
24.24.1 BUSINESS OVERVIEW
24.24.2 PRODUCT OFFERINGS
24.25 OMRON HEALTHCARE
24.25.1 BUSINESS OVERVIEW
24.25.2 PRODUCT OFFERINGS
24.26 OSPLABS
24.26.1 BUSINESS OVERVIEW
24.26.2 PRODUCT OFFERINGS
24.27 SMITHS MEDICAL
24.27.1 BUSINESS OVERVIEW
24.27.2 PRODUCT OFFERINGS
24.28 SPACELABS HEALTHCARE
24.28.1 BUSINESS OVERVIEW
24.28.2 PRODUCT OFFERINGS
24.29 SENSEONICS
24.29.1 BUSINESS OVERVIEW
24.29.2 PRODUCT OFFERINGS
24.30 TELEMEDCARE
24.30.1 BUSINESS OVERVIEW
24.30.2 PRODUCT OFFERINGS
24.31 VITALCONNECT
24.31.1 BUSINESS OVERVIEW
24.31.2 PRODUCT OFFERINGS
24.32 VITLS
24.32.1 BUSINESS OVERVIEW
24.32.2 PRODUCT OFFERINGS
24.33 MODICARE
24.33.1 BUSINESS OVERVIEW
24.33.2 PRODUCT OFFERINGS
24.34 HILLROM
24.34.1 BUSINESS OVERVIEW
24.34.2 PRODUCT OFFERINGS
24.35 VIVIFY HEALTH
24.35.1 BUSINESS OVERVIEW
24.35.2 PRODUCT OFFERING
24.36 ACL DIGITAL
24.36.1 BUSINESS OVERVIEW
24.36.2 PRODUCT OFFERINGS
24.37 DEXCOM
24.37.1 BUSINESS OVERVIEW
24.37.2 PRODUCT OFFERING
24.38 IRHYTHM TECHNOLOGIES
24.38.1 BUSINESS OVERVIEW
24.38.2 PRODUCT OFFERING
24.39 VIVALINK
24.39.1 BUSINESS OVERVIEW
24.39.2 PRODUCT OFFERING
24.40 BIOBEAT
24.40.1 BUSINESS OVERVIEW
24.40.2 PRODUCT OFFERINGS
24.41 CAREVALIDATE
24.41.1 BUSINESS OVERVIEW
24.41.2 PRODUCT OFFERINGS
24.42 BIOFOURMIS
24.42.1 BUSINESS OVERVIEW
24.42.2 PRODUCT OFFERING
24.43 CAREMINDR
24.43.1 BUSINESS OVERVIEW
24.43.2 PRODUCT OFFERING
24.44 DATOS HEALTH
24.44.1 BUSINESS OVERVIEW
24.44.2 PRODUCT OFFERINGS
25 REPORT SUMMARY
25.1 KEY TAKEAWAYS
25.2 STRATEGIC RECOMMENDATIONS
26 QUANTITATIVE SUMMARY
26.1 MARKET BY GEOGRAPHY
26.2 MARKET BY COMPONENTS
26.2.1 MARKET BY DEVICES & SOFTWARE
26.2.2 MARKET BY CARDIAC MONITORING DEVICES
26.2.3 MARKET BY RESPIRATORY MONITORING DEVICES
26.3 MARKET BY APPLICATION
26.4 MARKET BY END-USER
26.5 NORTH AMERICA: BY COMPONENTS
26.5.1 DEVICES & SOFTWARE
26.5.2 CARDIAC MONITORING DEVICES
26.5.3 RESPIRATORY MONITORING DEVICES
26.6 NORTH AMERICA: BY APPLICATION
26.7 NORTH AMERICA: BY END-USER
26.8 EUROPE: BY COMPONENTS
26.8.1 DEVICES & SOFTWARE
26.8.2 CARDIAC MONITORING DEVICES
26.8.3 RESPIRATORY MONITORING DEVICES
26.9 EUROPE: BY APPLICATION
26.10 EUROPE: BY END-USER
26.11 APAC: BY COMPONENTS
26.11.1 DEVICES & SOFTWARE
26.11.2 CARDIAC MONITORING DEVICES
26.11.3 RESPIRATORY MONITORING DEVICES
26.12 APAC: BY APPLICATION
26.13 APAC: BY END-USER
26.14 LATIN AMERICA: BY COMPONENTS
26.14.1 DEVICES & SOFTWARE
26.14.2 CARDIAC MONITORING DEVICES
26.14.3 RESPIRATORY MONITORING DEVICES
26.15 LATIN AMERICA: BY APPLICATION
26.16 LATIN AMERICA: BY END-USER
26.17 MIDDLE EAST & AFRICA: BY COMPONENTS
26.17.1 DEVICES & SOFTWARE
26.17.2 CARDIAC MONITORING DEVICES
26.17.3 RESPIRATORY MONITORING DEVICES
26.18 MIDDLE EAST & AFRICA: BY APPLICATION
26.19 MIDDLE EAST & AFRICA: BY END-USER
27 APPENDIX
27.1 ABBREVIATIONS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings